Efficacy and safety of immunosuppressive therapies in the treatment of high-risk IgA nephropathy: A network meta-analysis.
Tongtong LiuYuyang WangHuimin MaoLiping YangYongli ZhanPublished in: Medicine (2021)
MMF+CS and LEF+CS appear to serve as the best choice for treating high-risk IgAN than other immunosuppressive therapies.
Keyphrases